Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — |
| R&D | $0 | $0 | $0 | $0 |
| Operating income | −$6.3K | −$200.0K | −$929.0K | −$914.0K |
| EBITDA | −$6.3K | −$85.2K | $452.4K | $1.1M |
| Net income | −$6.3M | −$85.2K | $451.5K | $107.2K |
| Net margin | — | — | — | — |
| EPS (diluted) | -0.00 | -0.01 | 0.07 | 0.06 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds KACL.
No tracked institution reports a position in KACL as of their last filing.
No one on the platform has traded KACL yet.
| -4.35% |
| $50M |
| — |
| EUCREucrates Biomedical Acquisition Corp. | $10.04 | +0.00% | $42M | — |
| GRDIGRIID Infrastructure Inc. Common Stock | $0.96 | -1.00% | $68M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.